Data / Form D filings / Medcura, Inc.
Medcura, Inc.: Form D filings
Medcura, Inc., a biotechnology company in Riverdale, MD, filed 9 Form D notices with the SEC between 2016 and 2025. The latest, on July 25, 2025, reports $28.5 million sold of a $38.3 million offering to 174 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 5650 RIVERTECH COURT, SUITE S, Riverdale, MD, 20737
- Phone
- (301) 405-3585
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1672180
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 25, 2025 | New notice | $38,286,410 | $28,548,588 | $9,737,822 | 174 | Apr 16, 2025 | sec.gov |
| Jul 24, 2024 | Amendment | $22,800,000 | $22,486,953 | $313,047 | 151 | Jul 29, 2022 | sec.gov |
| Aug 16, 2022 | New notice | $5,600,000 | $3,207,050 | $2,392,950 | 26 | Jul 29, 2022 | sec.gov |
| Nov 2, 2021 | New notice | $5,761,644 | $3,490,000 | $2,271,644 | 45 | Oct 15, 2021 | sec.gov |
| Sep 28, 2020 | New notice | $5,000,000 | $3,021,475 | $1,978,525 | 55 | Jun 19, 2020 | sec.gov |
| Jul 2, 2018 | New notice | $2,500,000 | $1,561,500 | $938,500 | 36 | Jun 18, 2018 | sec.gov |
| Nov 10, 2016 | Amendment | $3,100,000 | $1,072,281 | $2,027,719 | 14 | Sep 9, 2016 | sec.gov |
| Sep 20, 2016 | New notice | $3,100,000 | $93,153 | $3,006,847 | 2 | Sep 9, 2016 | sec.gov |
| Apr 14, 2016 | New notice | $200 | $11 | $189 | 1 | Mar 29, 2016 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Rich Vincent | Executive Officer | |
| Jim Buck | Director, Executive Officer | |
| Larry Tiffany | Director, Executive Officer | |
| Abbas Ardehali, M.D. | Director | |
| Matthew Dowling, Ph.D | Director, Executive Officer |
Other biotechnology companies in Maryland that filed recently
- Accufy Diagnostics, Inc. $2 million · Oct 28, 2026
- OS Therapies Inc $7.2 million · Oct 23, 2026
- Kaigene, Inc. $55 million · Oct 14, 2026
- Templar Nova, Inc. $7 million · Oct 7, 2026
- Monocacy Therapeutics Inc. $25,000 · Oct 7, 2026
- Seraxis Holdings, Inc. $10 million · Sep 24, 2026
Every Form D from the week of Jul 21, 2025 · All recent filings in Maryland · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Medcura, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.